Research Article

Association between Insulin-Like Growth Factor-1 and Relative Skeletal Maturation: A Retrospective Cohort Study of Short Children and Adolescents

Table 1

Clinical and laboratory characteristics of the subjects.

VariableTotalDelayed bone ageNormal bone age

Number (%)783 (100%)457 (58.37%)326 (41.63%)
GH treatment (%)229 (100%)135 (58.95%)94 (41.05%)
Sex (male %)553 (70.63%)342 (74.84%)211 (64.72%)0.002
Chronological age (years)<0.001
Bone age (years)<0.001
BA-CA (years)-1.98 (-2.84–-1.28)-2.70 (-3.32–-2.22)-1.09 (-1.43–-0.59)<0.001
Height (cm)<0.001
Height SDS0.007
Body weight (kg)<0.001
BMI (kg/m2)<0.001
BMI SDS0.005
IGF-1 (ng/ml)164.00 (92.30-253.50)128.50 (76.62-196.00)232.00 (139.00-340.00)<0.001
IGF-1 SDS-1.03 (-1.86–-0.19)-1.21 (-1.93–-0.52)-0.58 (-1.63-0.35)<0.001
FT3 (pmol/l)0.306
FT4 (pmol/l)0.261
TSH (mIU/l)0.178
ALP (U/l)<0.001
E2 (pg/ml)18.15 (11.80-26.31)16.64 (11.80-23.41)20.80 (13.48-28.66)<0.001
T (pg/ml)0.23 (0.12-0.47)0.20 (0.10-0.32)0.29 (0.16-0.97)<0.001
FSH (mIU/ml)2.34 (1.01-3.96)1.75 (0.73-3.43)3.14 (1.78-4.68)0.011
LH (mIU/ml)0.22 (0.10-1.40)0.10 (0.04-0.94)0.82 (0.10-1.99)<0.001
Pubertal stage<0.001
 In prepuberty (%)579 (73.95%)385 (84.25%)194 (59.51%)
 In puberty (%)204 (26.05%)72 (15.75%)132 (40.49%)

Abbreviations: GH: growth hormone; BA-CA: bone age-chronological age; height SDS: height standard deviation scores; BMI: body mass index; BMI SDS: body mass index standard deviation scores; IGF-1: insulin-like growth factor-1; IGF-1 SDS: insulin-like growth factor-1 standard deviation scores; FT3: triiodothyronine; FT4: free thyroxine; TSH: thyrotrophic hormone; ALP: alkaline phosphatase; E2: estradiol; T: testosterone; FSH: follicle stimulating hormone; LH: luteinizing hormone. Delayed BA group was defined as , and normal BA group was defined as . Normal distribution of data was presented as ; nonnormal distribution of data was presented as median (interquartile range) and categorical data using number (percentage). is considered to be statistically significant.